Literature DB >> 2428070

Antiviral and other bioactivities of pyrimidinones.

W Wierenga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2428070     DOI： 10.1016/0163-7258(85)90048-8

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN： 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  10 in total

1.  Molecular Events as Targets of Anticancer Drug Therapy.

Authors:  Adorján Aszalós; Sándor Eckhardt
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

2.  Broad-spectrum in vivo antiviral activity of 7-thia-8-oxoguanosine, a novel immunopotentiating agent.

Authors:  D F Smee; H A Alaghamandan; H B Cottam; B S Sharma; W B Jolley; R K Robins
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

3.  A phase II clinical trial of oral bropirimine in combination with intravesical bacillus Calmette-Guérin for carcinoma in situ of the bladder: a Southwest Oncology Group Study.

Authors:  Michael F Sarosdy; Catherine M Tangen; Geoffrey R Weiss; Blake R Nestok; Mitchell C Benson; Paul F Schellhammer; Arthur I Sagalowsky; David P Wood; E David Crawford
Journal:  Urol Oncol       Date:  2005 Nov-Dec       Impact factor: 3.498

Review 4.  Roles of interferon produced in physiological conditions. A speculative review.

Authors:  V Bocci
Journal:  Immunology       Date:  1988-05       Impact factor: 7.397

5.  Immunoenhancing properties and antiviral activity of 7-deazaguanosine in mice.

Authors:  D F Smee; H A Alaghamandan; J Gilbert; R A Burger; A Jin; B S Sharma; K Ramasamy; G R Revankar; H B Cottam; W B Jolley
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

6.  Antitumor effects of oral administration of an interferon-inducing pyrimidinone, Bropirimine, on murine renal-cell carcinoma.

Authors:  T Fujioka; K Ishikura; M Hasegawa; K Ogyu; Y Matsushita; M Sato; F Sato; H Aoki; T Kubo
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

Review 7.  Biologic response modifiers in the management of superficial bladder cancer.

Authors:  S Serels; J Fleischmann
Journal:  World J Urol       Date:  1997       Impact factor: 3.661

8.  Comparative computational studies of 3,4-dihydro-2,6-diaryl-4-oxo-pyrimidine-5-carbonitrile derivatives as potential antinociceptive agents.

Authors:  Janaína V dos Anjos; Rajendra M Srivastava; João H Costa-Silva; Luciana Scotti; Marcus T Scotti; Almir G Wanderley; Elisa Soares Leite; Sebastião J de Melo; Francisco J B Mendonça Junior
Journal:  Molecules       Date:  2012-01-16       Impact factor: 4.411

9.  Prophylactic and therapeutic activities of 7-thia-8-oxoguanosine against Punta Toro virus infections in mice.

Authors:  D F Smee; J H Huffman; A C Gessaman; J W Huggins; R W Sidwell
Journal:  Antiviral Res       Date:  1991 Mar-Apr       Impact factor: 5.970

Review 10.  Biophysical analysis of SARS-CoV-2 transmission and theranostic development via N protein computational characterization.

Authors:  Godfred O Sabbih; Maame A Korsah; Jaison Jeevanandam; Michael K Danquah
Journal:  Biotechnol Prog       Date:  2020-11-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.